05
05
Skills in Demand
Skills in Demand: Top Divisions Biotechnology Sector, Scientific vacancies, 2021-2023 *Est, UK
Skills in Demand: Top Divisions Biotechnology Sector, Scientific vacancies, 2021-2023 *Est, EU
R&D
R&D
Quality Assurance
Quality Assurance
Clinical
Clinical
Regulatory Affairs
Drug Manufacturing
Scientific Support
Medical Affairs & Medical Information
250
500
750
1,000
1,250
500
1,000
1,500
2,000
2023*
2023*
2021
2021
2022
2022
Source: Vacancysoft Analytics
Source: Vacancysoft Analytics
*- Forecast 2023
*- Forecast 2023
Fig. 05
Fig. 06
The UK biotech sector 2023 continues to underscore the critical importance of Research and Development (R&D), which retains the largest market share at 57.3%, despite a significant 47.4% decrease in vacancies from the previous year. This fall follows a modest 1.9% rise in 2022, a year that otherwise marked downturns across various skill sets. Regulatory Affairs experienced the most considerable decline, with a 50% drop in job openings, illustrating the impact of industry shifts on regulatory roles. Despite facing a 42.5% decrease in vacancies, Quality Assurance saw its market share grow to 13.9%, reflecting its sustained essential role within the sector. With an 8.2% market share, the Clinical division remains a consistent demand area despite a 45.8% drop in opportunities. Scientific Support witnessed the second-largest reduction at 48.5%, indicative of the broader trend affecting specialised roles within the industry. Overall, the sharp decline in job openings across all divisions suggests a period of recalibration for the UK’s biotech sector as it navigates the post-pandemic landscape and adjusts to new economic realities.
In the EU27, 2023 has been a year of change for skill demand within the biotechnology sector; R&D remains the predominant division despite a significant 42.4% year-on-year vacancy reduction, retaining a 33.0% share of the job market. This notable decrease follows a positive trend in 2022. The Drug Manufacturing and Medical Affairs & Medical Information divisions are unique to the EU27’s top demands, reflecting the region’s robust manufacturing sector. However, both divisions have experienced significant declines, with Drug Manufacturing witnessing a 41.1% drop in vacancies. This trend is a departure from the previous year’s 43.5% increase, suggesting a post-pandemic normalisation following an initial surge in demand. Quality Assurance, after a 16.1% increase in 2022, faced a downturn with a 39.7% decline in 2023. Conversely, the Clinical division, although seeing a reduction in roles, appears to be the least affected, with a more minor 12.5% year-on-year change and an increase in market share to 10.9%.
Made with FlippingBook - Share PDF online